T1	PROC 46 60	Ensayo clínico
#1	AnnotatorNotes T1	C0008976; Clinical Trials; Research Activity
T2	DISO 163 171	COVID-19
#2	AnnotatorNotes T2	C5203670; COVID19 (disease); Disease or Syndrome
T3	CHEM 94 111	hidroxicloroquina
#3	AnnotatorNotes T3	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T4	CHEM 113 125	azitromicina
#4	AnnotatorNotes T4	C0052796; azithromycin; Antibiotic · Organic Chemical
T5	CHEM 128 139	tocilizumab
#5	AnnotatorNotes T5	C1609165; tocilizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T6	PROC 148 159	tratamiento
#6	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	PROC 194 254	Ensayo clínico piloto, aleatorizado, multicéntrico y abierto
T8	CHEM 275 292	hidroxicloroquina
#7	AnnotatorNotes T8	C0020336; hydroxychloroquine; Organic Chemical · Pharmacologic Substance
T9	CHEM 294 306	azitromicina
#8	AnnotatorNotes T9	C0052796; azithromycin; Antibiotic · Organic Chemical
T10	CHEM 309 320	tocilizumab
#9	AnnotatorNotes T10	C1609165; tocilizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T11	PROC 329 340	tratamiento
#10	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	DISO 347 371	infección por SARS-CoV-2
#11	AnnotatorNotes T12	C5203670; COVID19 (disease); Disease or Syndrome
T13	DISO 373 381	COVID-19
#12	AnnotatorNotes T13	C5203670; COVID19 (disease); Disease or Syndrome
T14	PROC 575 588	procedimiento
#13	AnnotatorNotes T14	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T15	PROC 635 649	procedimientos
#14	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T16	PROC 511 547	consentimiento informado por escrito
#15	AnnotatorNotes T16	C0811741; Obtain informed written consent; Health Care Activity
T17	DISO 406 413	COVID19
#16	AnnotatorNotes T17	C5203670; COVID19 (disease); Disease or Syndrome
T18	DISO 754 778	infección por SARS-CoV-2
#17	AnnotatorNotes T18	C5203670; COVID19 (disease); Disease or Syndrome
T19	PROC 836 850	aleatorización
#18	AnnotatorNotes T19	C0034656; Randomization; Research Activity
T20	PROC 981 1002	oxígeno suplementario
#19	AnnotatorNotes T20	C0919655; Oxygen supplementation; Therapeutic or Preventive Procedure
T21	PROC 950 963	Hospitalizado
#20	AnnotatorNotes T21	C0019993; Hospitalization; Health Care Activity
T22	CHEM 981 988	oxígeno
#21	AnnotatorNotes T22	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T23	PROC 1017 1030	Hospitalizado
#22	AnnotatorNotes T23	C0019993; Hospitalization; Health Care Activity
T24	CHEM 1045 1052	oxígeno
#23	AnnotatorNotes T24	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T25	PROC 1169 1171	FG
#24	AnnotatorNotes T25	C0017654; Glomerular Filtration Rate; Diagnostic procedure
T26	PROC 1045 1066	oxígeno suplementario
#25	AnnotatorNotes T26	C0919655; Oxygen supplementation; Therapeutic or Preventive Procedure
T27	DISO 1133 1157	Enfermedad renal crónica
#26	AnnotatorNotes T27	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T28	DISO 1217 1231	comorbilidades
#27	AnnotatorNotes T28	C1275743; Co-morbid conditions; Finding
T29	PROC 1356 1378	traslado a otro centro
#28	AnnotatorNotes T29	C0030704; Patient Transfer; Health Care Activity
T30	DISO 1288 1296	Demencia
#29	AnnotatorNotes T30	C0497327; Dementia; Mental or Behavioral Dysfunction
T31	DISO 1421 1428	Alergia
#30	AnnotatorNotes T31	C1527304; Allergic Reaction; Pathologic Function
T32	PROC 1903 1910	tratada
#31	AnnotatorNotes T32	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T33	DISO 1460 1483	Infecciones bacterianas
#32	AnnotatorNotes T33	C0004623; Bacterial Infections; Disease or Syndrome
T34	DISO 1503 1509	sepsis
#33	AnnotatorNotes T34	C0243026; Sepsis; Disease or Syndrome
T35	PROC 1571 1610	Antigenuria de Streptococcus pneumoniae
#34	AnnotatorNotes T35	C1294960; Streptococcus pneumoniae antigen assay; Laboratory Procedure
T36	DISO 1653 1664	Neutropenia
#35	AnnotatorNotes T36	C0027947; Neutropenia; Disease or Syndrome | C0853697; Neutrophil count decreased; Finding
T37	DISO 1679 1692	Plaquetopenia
#36	AnnotatorNotes T37	C0040034; Thrombocytopenia; Disease or Syndrome
T38	DISO 1723 1737	diverticulosis
#37	AnnotatorNotes T38	C1510475; Diverticulosis; Disease or Syndrome | C4317009; Diverticular Diseases; Disease or Syndrome
T39	DISO 1743 1760	Infección cutánea
T40	DISO 1784 1795	piodermitis
#38	AnnotatorNotes T40	C0034212; Pyoderma; Disease or Syndrome
T41	PROC 1811 1823	trasplantado
#39	AnnotatorNotes T41	C0040732; Transplantation; Therapeutic or Preventive Procedure
T42	PROC 1827 1853	tratamiento inmunosupresor
#40	AnnotatorNotes T42	C0021079; Therapeutic immunosuppression; Therapeutic or Preventive Procedure
T43	DISO 1879 1899	tuberculosis latente
#41	AnnotatorNotes T43	C1609538; Latent Tuberculosis; Disease or Syndrome
T44	PROC 792 813	prueba microbiológica
T45	PROC 1096 1099	ALT
#42	AnnotatorNotes T45	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T46	PROC 1100 1103	AST
#43	AnnotatorNotes T46	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T47	ANAT 1144 1149	renal
#44	AnnotatorNotes T47	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T48	PROC 1192 1200	diálisis
#45	AnnotatorNotes T48	C0011946; Dialysis procedure; Therapeutic or Preventive Procedure | C4551529; Renal Dialysis; Therapeutic or Preventive Procedure
T49	CHEM 1434 1444	medicación
#46	AnnotatorNotes T49	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T50	ANAT 1753 1760	cutánea
#47	AnnotatorNotes T50	C0011646; Dermis; Tissue | C1123023; Skin; Body System
T51	CHEM 1839 1853	inmunosupresor
#48	AnnotatorNotes T51	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T52	Date 13 17	2020
T53	LIVB 443 449	Sujeto
#49	AnnotatorNotes T53	C0681850; Study Subject; Group
T54	LIVB 453 472	representante legal
#50	AnnotatorNotes T54	C4288823; Legal Representative for the Study; Human
T56	LIVB 666 672	Adulto
#51	AnnotatorNotes T56	C0001675; Adult; Age Group
T57	Age 673 681	≥18 años
T58	Neg_cue 852 854	no
T59	Duration 855 871	mayor a 72 horas
T61	Neg_cue 969 971	no
T62	Duration 1150 1157	crónica
#52	AnnotatorNotes T62	C0205191; chronic; Temporal Concept
T63	PHYS 1310 1318	Embarazo
#53	AnnotatorNotes T63	C0032961; Pregnancy; Organism Function
T64	PHYS 1321 1338	lactancia materna
#54	AnnotatorNotes T64	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T66	Duration 1382 1394	las 12 horas
T67	LIVB 1556 1566	SARS-CoV-2
#55	AnnotatorNotes T67	C5203676; SARS-CoV-2; Virus
T68	LIVB 1586 1610	Streptococcus pneumoniae
#56	AnnotatorNotes T68	C0038410; Streptococcus pneumoniae; Bacterium
T69	LIVB 1802 1810	Paciente
#57	AnnotatorNotes T69	C0030705; Patients; Patient or Disabled Group
T70	Neg_cue 1900 1902	no
T72	LIVB 1472 1483	bacterianas
#58	AnnotatorNotes T72	C0004611; Bacteria; Bacterium
T73	LIVB 1532 1541	patógenos
#59	AnnotatorNotes T73	C0450254; Pathogenic organism; Organism
T74	LIVB 361 371	SARS-CoV-2
#60	AnnotatorNotes T74	C5203676; SARS-CoV-2; Virus
T75	LIVB 768 778	SARS-CoV-2
#61	AnnotatorNotes T75	C5203676; SARS-CoV-2; Virus
T55	PHYS 605 613	Entienda
#62	AnnotatorNotes T55	C0162340; Comprehension; Mental Process
T60	Neg_cue 1542 1555	diferentes de
T65	Date 1761 1769	en curso
T71	LIVB 1331 1338	materna
#63	AnnotatorNotes T71	C0026591; Mother (person); Family Group
A1	Assertion T59 Negated
A2	Assertion T20 Negated
A3	Assertion T22 Negated
A4	Assertion T67 Negated
A5	Assertion T32 Negated
A6	Population_data T56 Age
A7	Status T31 History_of
A8	Status T38 History_of
A9	Status T41 History_of
A10	Status T43 History_of
#64	AnnotatorNotes T7	C0031928; Pilot Projects; Research Activity + C0034656; Randomization; Research Activity + C1096776; Multicenter Study; Research Activity + C1709323; Open Label Study; Research Activity 
#65	AnnotatorNotes T39	C0037278; Skin Diseases, Infectious; Disease or Syndrome 
R1	Combined_with Arg1:T3 Arg2:T4	
R2	Combined_with Arg1:T4 Arg2:T5	
R3	Used_for Arg1:T3 Arg2:T6	
R4	Combined_with Arg1:T8 Arg2:T9	
R5	Combined_with Arg1:T9 Arg2:T10	
R6	Used_for Arg1:T8 Arg2:T11	
R7	Causes Arg1:T74 Arg2:T12	
R8	Causes Arg1:T74 Arg2:T13	
T76	Observation 473 483	autorizado
#66	AnnotatorNotes T76	C1555472; Authorized; Finding
R9	Has_Quantifier_or_Qualifier Arg1:T54 Arg2:T76	
R10	Before Arg1:T16 Arg2:T14	
R11	Experiences Arg1:T53 Arg2:T14	
T77	Observation 616 649	acepte cumplir los procedimientos
R12	Overlap Arg1:T55 Arg2:T15	
R13	Overlap Arg1:T77 Arg2:T15	
R14	Experiences Arg1:T71 Arg2:T64	
R15	Experiences Arg1:T71 Arg2:T63	
R16	Has_Age Arg1:T56 Arg2:T57	
T78	CONC 707 716	inclusión
#67	AnnotatorNotes T78	C1512693; Inclusion; Qualitative Concept
R17	Overlap Arg1:T57 Arg2:T78	
R18	Causes Arg1:T75 Arg2:T18	
R20	Before Arg1:T44 Arg2:T19	
R21	Negation Arg1:T58 Arg2:T59	
R22	Overlap Arg1:T44 Arg2:T59	
#68	AnnotatorNotes T44	C0085672; Microbiology procedure; Laboratory Procedure
T79	Result_or_Value 876 888	Gravedad 3-4
T80	CONC 898 934	escala ordinal de 7 puntos de la OMS
R23	Has_Result_or_Value Arg1:T80 Arg2:T79	
T81	Result_or_Value 938 948	Gravedad 3
R24	Overlap Arg1:T21 Arg2:T20	
R25	Used_for Arg1:T22 Arg2:T20	
R26	Negation Arg1:T61 Arg2:T22	
R27	Negation Arg1:T61 Arg2:T20	
R28	Overlap Arg1:T23 Arg2:T26	
R29	Used_for Arg1:T24 Arg2:T26	
T82	Result_or_Value 1005 1015	Gravedad 4
T83	Result_or_Value 1104 1129	>5 veces el límite normal
R30	Has_Result_or_Value Arg1:T46 Arg2:T83	
R31	Has_Result_or_Value Arg1:T45 Arg2:T83	
R32	Location_of Arg1:T47 Arg2:T27	
R33	Has_Duration_or_Interval Arg1:T27 Arg2:T62	
T84	Quantifier_or_Qualifier 1158 1167	estadio 4
R34	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T84	
T85	Result_or_Value 1172 1175	<30
R35	Has_Result_or_Value Arg1:T25 Arg2:T85	
T86	Observation 1246 1260	mal pronóstico
#69	AnnotatorNotes T86	C0278252; Prognosis bad; Finding
R37	Overlap Arg1:T28 Arg2:T86	
T87	Quantifier_or_Qualifier 1297 1305	avanzada
#70	AnnotatorNotes T87	C0205179; Advanced phase; Qualitative Concept
R38	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T87	
R39	After Arg1:T29 Arg2:T66	
T88	CONC 1398 1416	inicio del estudio
#71	AnnotatorNotes T88	C4684789; Study Start; Temporal Concept | C2349982; Study start time; Temporal Concept
R40	Overlap Arg1:T29 Arg2:T88	
T89	Quantifier_or_Qualifier 1343 1352	Previsión
#72	AnnotatorNotes T89	C1301732; Planned; Functional Concept
R41	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T89	
R42	Causes Arg1:T49 Arg2:T31	
R43	Causes Arg1:T72 Arg2:T33	
R44	Causes Arg1:T73 Arg2:T34	
R45	Negation Arg1:T60 Arg2:T67	
T90	Quantifier_or_Qualifier 1484 1491	activas
#73	AnnotatorNotes T90	C0679217; Active State; Idea or Concept
R46	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T90	
T91	Quantifier_or_Qualifier 1494 1500	graves
#74	AnnotatorNotes T91	C1547227; Severe - Severity of Illness Code; Intellectual Product
R47	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T91	
T92	CONC 1629 1647	inicio del estudio
#75	AnnotatorNotes T92	C4684789; Study Start; Temporal Concept | C2349982; Study start time; Temporal Concept
R48	Before Arg1:T35 Arg2:T92	
T93	Result_or_Value 1611 1619	positivo
#76	AnnotatorNotes T93	C1446409; Positive; Finding
R49	Has_Result_or_Value Arg1:T35 Arg2:T93	
R50	Before Arg1:T93 Arg2:T92	
R51	Causes Arg1:T68 Arg2:T93	
T94	Result_or_Value 1665 1673	<500/mm3
T95	Result_or_Value 1693 1705	<100.000/mm3
R52	Has_Result_or_Value Arg1:T37 Arg2:T95	
R53	Has_Result_or_Value Arg1:T36 Arg2:T94	
R54	Location_of Arg1:T50 Arg2:T39	
R55	Overlap Arg1:T39 Arg2:T65	
R56	Overlap Arg1:T40 Arg2:T65	
R57	Experiences Arg1:T69 Arg2:T41	
R58	Experiences Arg1:T69 Arg2:T42	
R59	Used_for Arg1:T51 Arg2:T42	
R60	Overlap Arg1:T41 Arg2:T42	
R61	Negation Arg1:T70 Arg2:T32	
#77	AnnotatorNotes T65	C0521116; Current (present time); Temporal Concept
A11	Experiencer T54 Other
A12	Experiencer T53 Patient
A13	Experiencer T56 Patient
A14	Experiencer T71 Patient
A15	Experiencer T69 Patient
